middle.news
IDT Australia Narrows FY26 EBITDA Loss 85% with $7.3M Capex Boost
10:35am on Thursday 20th of August, 2026 AEST
•
Pharmaceuticals
Read Story
IDT Australia Narrows FY26 EBITDA Loss 85% with $7.3M Capex Boost
10:35am on Thursday 20th of August, 2026 AEST
Key Points
FY26 revenue up 3.4% to $20.5 million
Net loss shrinks 66% to $2.7 million
EBITDA loss narrows 85% to $0.9 million
$7.3 million capex program to expand sterile and solid oral manufacturing
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Idt Australia (ASX:IDT)
OPEN ARTICLE